Based on all the evidence, GLP-1 RAs offer multifaceted protective effects against atherosclerosis in diabetic patients through mechanisms that enhance endothelial function, reduce oxidative stress and inflammation, inhibit VSMC proliferation, stabilize plaques, and mitigate thrombosis. This evidence concerns the gene GCG and atherosclerosis.